Literature DB >> 23212054

ECT in treatment-resistant depression.

Charles H Kellner1, Robert M Greenberg, James W Murrough, Ethan O Bryson, Mimi C Briggs, Rosa M Pasculli.   

Abstract

Electroconvulsive therapy (ECT), which has been in use for 75 years, is an important treatment for severe and treatment-resistant depression. Although it is acknowledged as the most effective acute treatment for severe mood and psychotic disorders, it remains controversial because of misperceptions about its use and lack of familiarity among health care professionals about modern ECT technique. The authors present an illustrative case of a patient for whom ECT is indicated. They review the basic and clinical science related to ECT's mechanism of action and discuss clinical issues in the administration of a course of ECT, including the consent process.

Entities:  

Mesh:

Year:  2012        PMID: 23212054     DOI: 10.1176/appi.ajp.2012.12050648

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  55 in total

1.  Short- and Long-term Cognitive Outcomes in Patients With Major Depression Treated With Electroconvulsive Therapy.

Authors:  Megha M Vasavada; Amber M Leaver; Stephanie Njau; Shantanu H Joshi; Linda Ercoli; Gerhard Hellemann; Katherine L Narr; Randall Espinoza
Journal:  J ECT       Date:  2017-12       Impact factor: 3.635

Review 2.  Ketamine enantiomers in the rapid and sustained antidepressant effects.

Authors:  John Muller; Sahana Pentyala; James Dilger; Srinivas Pentyala
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-10

Review 3.  Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression.

Authors:  Emma T Geduldig; Charles H Kellner
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

4.  Treatment-resistant depression requiring electroconvulsive therapy following stem cell transplantation.

Authors:  Dana Raml; Matthew Kelly; Ashish Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2014-08-28

5.  Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.

Authors:  Søren D Østergaard; Maria S Speed; Charles H Kellner; Martina Mueller; Shawn M McClintock; Mustafa M Husain; Georgios Petrides; William V McCall; Sarah H Lisanby
Journal:  J Affect Disord       Date:  2020-05-23       Impact factor: 4.839

6.  Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.

Authors:  Charles H Kellner; Mustafa M Husain; Rebecca G Knapp; W Vaughn McCall; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shirlene Sampson; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Peter B Rosenquist; Ahmad Raza; Styliani Kaliora; Vassilios Latoussakis; Kristen G Tobias; Mimi C Briggs; Lauren S Liebman; Emma T Geduldig; Abeba A Teklehaimanot; Sarah H Lisanby
Journal:  Am J Psychiatry       Date:  2016-07-15       Impact factor: 18.112

7.  Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression.

Authors:  Stephanie Njau; Shantanu H Joshi; Randall Espinoza; Amber M Leaver; Megha Vasavada; Antonio Marquina; Roger P Woods; Katherine L Narr
Journal:  J Psychiatry Neurosci       Date:  2017-01       Impact factor: 6.186

8.  Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy.

Authors:  Eunice Hagen; Dana Shprung; Elena Minakova; James Washington; Udaya Kumar; Don Shin; Raman Sankar; Andrey Mazarati
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

9.  A functional MRI marker may predict the outcome of electroconvulsive therapy in severe and treatment-resistant depression.

Authors:  J A van Waarde; H S Scholte; L J B van Oudheusden; B Verwey; D Denys; G A van Wingen
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

10.  Gadd45b Mediates Electroconvulsive Shock Induced Proliferation of Hippocampal Neural Stem Cells.

Authors:  Heechul Jun; Syed Mohammed Qasim Hussaini; Chang Hoon Cho; John Welby; Mi-Hyeon Jang
Journal:  Brain Stimul       Date:  2015-07-28       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.